While this drug acts by antagonizing the IL-17A Receptor, CosentyxTM and TaltzTM antagonize the pro-inflammatory cytokine IL-17A, which plays a role in psoriasis and Psa [67,69]. The gene discussed is IL17A; the disease is psoriasis.